Skip to main content

Adenoma Detection Rate

0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Eppendorf
EppendorfGermany - Hamburg
2 programs
Endocuff groupN/A
screening colonoscopyN/A1 trial
Active Trials
NCT03137277Completed1,221Est. Jul 2017
Angeles Therapeutics
Angeles TherapeuticsCA - Los Angeles
1 program
Comparison of ADRN/A1 trial
Active Trials
NCT05125939Recruiting2,700Est. Sep 2026
Evergreen Therapeutics
Evergreen TherapeuticsChina - Hong Kong
1 program
Comparison of ADRN/A
Norgine
NorgineAustria - Vienna
1 program
Endocuff groupN/A1 trial
Active Trials
NCT03442738Completed1,382Est. Sep 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Angeles TherapeuticsComparison of ADR
NorgineEndocuff group
Eppendorfscreening colonoscopy

Clinical Trials (3)

Total enrollment: 5,303 patients across 3 trials

NCT05125939Angeles TherapeuticsComparison of ADR

Can Overall Adenoma Detection Rate Replace Screening Adenoma Detection Rate ? Multicenter Study

Start: Nov 2021Est. completion: Sep 20262,700 patients
N/ARecruiting
NCT03442738NorgineEndocuff group

A Prospective Randomized Comparison of the Adenoma Detection Rate With a Disposable Cap (ENDOCUFF VISION®)

Start: Sep 2017Est. completion: Sep 20221,382 patients
N/ACompleted
NCT03137277Eppendorfscreening colonoscopy

A Study Between Two Instrument Generations to Improve Adenoma Detection in Screening Colonoscopy

Start: Nov 2013Est. completion: Jul 20171,221 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 5,303 patients
4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.